Viewing StudyNCT04474470



Ignite Creation Date: 2024-05-06 @ 2:57 PM
Last Modification Date: 2024-10-26 @ 1:40 PM
Study NCT ID: NCT04474470
Status: COMPLETED
Last Update Posted: 2024-05-09
First Post: 2020-06-30

Brief Title: A Study to Evaluate NT219 Alone and in Combination with ERBITUX Cetuximab in Adults with Advanced Solid Tumors and Head and Neck Cancer
Sponsor: TyrNovo Ltd
Organization: Purple Biotech Ltd

Conditions & Keywords Data

Conditions:
Name
Solid Tumor Adult
Squamous Cell Carcinoma of Head and Neck
Colorectal Adenocarcinoma
Metastatic Solid Tumor
Recurrent Solid Tumor
Head and Neck Cancer
Keywords:
Name View
Cetuximab View
NT219 View
ERBITUX View